166 related articles for article (PubMed ID: 37658095)
21. Untargeted NMR Metabolomics Reveals Alternative Biomarkers and Pathways in Alkaptonuria.
Grasso D; Geminiani M; Galderisi S; Iacomelli G; Peruzzi L; Marzocchi B; Santucci A; Bernini A
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555443
[TBL] [Abstract][Full Text] [Related]
22. First report of a deletion encompassing an entire exon in the homogentisate 1,2-dioxygenase gene causing alkaptonuria.
Zouheir Habbal M; Bou-Assi T; Zhu J; Owen R; Chehab FF
PLoS One; 2014; 9(9):e106948. PubMed ID: 25233259
[TBL] [Abstract][Full Text] [Related]
23. Mutation screening of the HGD gene identifies a novel alkaptonuria mutation with significant founder effect and high prevalence.
Sakthivel S; Zatkova A; Nemethova M; Surovy M; Kadasi L; Saravanan MP
Ann Hum Genet; 2014 May; 78(3):155-64. PubMed ID: 24575791
[TBL] [Abstract][Full Text] [Related]
24. A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria.
Bernini A; Petricci E; Atrei A; Baratto MC; Manetti F; Santucci A
Sci Rep; 2021 Nov; 11(1):22562. PubMed ID: 34799606
[TBL] [Abstract][Full Text] [Related]
25. First report of HGD mutations in a Chinese with alkaptonuria.
Yang YJ; Guo JH; Chen WJ; Zhao R; Tang JS; Meng XH; Zhao L; Tu M; He XY; Wu LQ; Zhu YM
Gene; 2013 Apr; 518(2):467-9. PubMed ID: 23353776
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the Phenotype Differences in Siblings with Alkaptonuria.
Zatkova A; Olsson B; Ranganath LR; Imrich R
Metabolites; 2022 Oct; 12(10):. PubMed ID: 36295892
[TBL] [Abstract][Full Text] [Related]
27. Alkaptonuria: a very rare metabolic disorder.
Aquaron R
Indian J Biochem Biophys; 2013 Oct; 50(5):339-44. PubMed ID: 24772955
[TBL] [Abstract][Full Text] [Related]
28. Alkaptonuria in Russia: mutational spectrum and novel variants.
Bychkov I; Kamenets E; Kurkina M; Rychkov G; Ilyushkina A; Filatova A; Guseva D; Baydakova G; Nekrasov A; Cheblokov A; Skoblov M; Zakharova E
Eur J Med Genet; 2021 Apr; 64(4):104165. PubMed ID: 33621656
[TBL] [Abstract][Full Text] [Related]
29. Identification of Potential Inhibitors for the Treatment of Alkaptonuria Using an Integrated In Silico Computational Strategy.
Zaib S; Rana N; Hussain N; Ogaly HA; Dera AA; Khan I
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985595
[TBL] [Abstract][Full Text] [Related]
30. Breakpoints characterisation of the genomic deletions identified by MLPA in alkaptonuria patients.
Soltysova A; Sekelska M; Zatkova A
Eur J Hum Genet; 2023 Apr; 31(4):485-489. PubMed ID: 35110678
[TBL] [Abstract][Full Text] [Related]
31. Transient pockets as mediators of gas molecules routes inside proteins: The case study of dioxygen pathway in homogentisate 1,2-dioxygenase and its implication in Alkaptonuria development.
Bernini A; Galderisi S; Spiga O; Amarabom CO; Santucci A
Comput Biol Chem; 2020 Oct; 88():107356. PubMed ID: 32823072
[TBL] [Abstract][Full Text] [Related]
32. The human gene for alkaptonuria (AKU) maps to chromosome 3q.
Janocha S; Wolz W; Srsen S; Srsnova K; Montagutelli X; Guénet JL; Grimm T; Kress W; Müller CR
Genomics; 1994 Jan; 19(1):5-8. PubMed ID: 8188241
[TBL] [Abstract][Full Text] [Related]
33. Molecular analyses of the HGO gene mutations in Turkish alkaptonuria patients suggest that the R58fs mutation originated from central Asia and was spread throughout Europe and Anatolia by human migrations.
Uyguner O; Goicoechea de Jorge E; Cefle A; Baykal T; Kayserili H; Cefle K; Demirkol M; Yuksel-Apak M; Rodriguez de Córdoba S; Wollnik B
J Inherit Metab Dis; 2003; 26(1):17-23. PubMed ID: 12872836
[TBL] [Abstract][Full Text] [Related]
34. Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria.
Laschi M; Tinti L; Braconi D; Millucci L; Ghezzi L; Amato L; Selvi E; Spreafico A; Bernardini G; Santucci A
J Cell Physiol; 2012 Sep; 227(9):3254-7. PubMed ID: 22105303
[TBL] [Abstract][Full Text] [Related]
35. Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria.
Galderisi S; Milella MS; Rossi M; Cicaloni V; Rossi R; Giustarini D; Spiga O; Tinti L; Salvini L; Tinti C; Braconi D; Millucci L; Lupetti P; Prischi F; Bernardini G; Santucci A
Arch Biochem Biophys; 2022 Mar; 717():109137. PubMed ID: 35090868
[TBL] [Abstract][Full Text] [Related]
36. Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria.
Bernardini G; Laschi M; Geminiani M; Braconi D; Vannuccini E; Lupetti P; Manetti F; Millucci L; Santucci A
J Inherit Metab Dis; 2015 Sep; 38(5):807-14. PubMed ID: 25762405
[TBL] [Abstract][Full Text] [Related]
37. Identification of the mutation in the alkaptonuria mouse model. Mutations in brief no. 216. Online.
Manning K; Fernández-Cañón JM; Montagutelli X; Grompe M
Hum Mutat; 1999; 13(2):171. PubMed ID: 10094559
[TBL] [Abstract][Full Text] [Related]
38. Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone.
Preston AJ; Keenan CM; Sutherland H; Wilson PJ; Wlodarski B; Taylor AM; Williams DP; Ranganath LR; Gallagher JA; Jarvis JC
Ann Rheum Dis; 2014 Jan; 73(1):284-9. PubMed ID: 23511227
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria.
Laschi M; Bernardini G; Dreassi E; Millucci L; Geminiani M; Braconi D; Marzocchi B; Botta M; Manetti F; Santucci A
ChemMedChem; 2016 Apr; 11(7):674-8. PubMed ID: 26947423
[TBL] [Abstract][Full Text] [Related]
40. Natural history of alkaptonuria.
Phornphutkul C; Introne WJ; Perry MB; Bernardini I; Murphey MD; Fitzpatrick DL; Anderson PD; Huizing M; Anikster Y; Gerber LH; Gahl WA
N Engl J Med; 2002 Dec; 347(26):2111-21. PubMed ID: 12501223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
